- Home
- FYBR vs RGEN Comparison
FYBR vs RGEN Comparison
Compare FYBR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FYBR
- RGEN
- Stock Information
- Founded
- FYBR 1935
- RGEN 1981
- Country
- FYBR United States
- RGEN United States
- Employees
- FYBR N/A
- RGEN N/A
- Industry
- FYBR Telecommunications Equipment
- RGEN Medical/Dental Instruments
- Sector
- FYBR Consumer Discretionary
- RGEN Health Care
- Exchange
- FYBR Nasdaq
- RGEN Nasdaq
- Market Cap
- FYBR 8.9B
- RGEN 9.0B
- IPO Year
- FYBR N/A
- RGEN N/A
- Fundamental
- Price
- FYBR $35.89
- RGEN $133.41
- Analyst Decision
- FYBR Buy
- RGEN Buy
- Analyst Count
- FYBR 10
- RGEN 12
- Target Price
- FYBR $34.57
- RGEN $177.78
- AVG Volume (30 Days)
- FYBR 3.9M
- RGEN 716.8K
- Earning Date
- FYBR 05-02-2025
- RGEN 04-30-2025
- Dividend Yield
- FYBR N/A
- RGEN N/A
- EPS Growth
- FYBR N/A
- RGEN N/A
- EPS
- FYBR N/A
- RGEN N/A
- Revenue
- FYBR $5,937,000,000.00
- RGEN $634,439,000.00
- Revenue This Year
- FYBR $4.33
- RGEN $12.02
- Revenue Next Year
- FYBR $2.94
- RGEN $14.99
- P/E Ratio
- FYBR N/A
- RGEN N/A
- Revenue Growth
- FYBR 3.23
- RGEN 0.33
- 52 Week Low
- FYBR $21.31
- RGEN $113.50
- 52 Week High
- FYBR $39.21
- RGEN $184.98
- Technical
- Relative Strength Index (RSI)
- FYBR 54.15
- RGEN 37.13
- Support Level
- FYBR $35.71
- RGEN $135.71
- Resistance Level
- FYBR $35.96
- RGEN $147.00
- Average True Range (ATR)
- FYBR 0.16
- RGEN 6.77
- MACD
- FYBR -0.01
- RGEN -1.03
- Stochastic Oscillator
- FYBR 72.50
- RGEN 12.78
About FYBR Frontier Communications Parent Inc.
Frontier Communications Parent Inc offers a variety of services to residential and business customers over its fiber-optic and copper networks, including video, high-speed internet, advanced voice, and Frontier Secure digital protection solutions. It offers communications solutions to small, medium, and enterprise businesses.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.